| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501814A Pharmaceutical compositions |
| 06/02/2004 | CN1501798A Medicinal compositions comprising diclofenac and ornoprostil |
| 06/02/2004 | CN1501795A Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 06/02/2004 | CN1500789A Complex ML(DCA) of copper(ó�), gallium(ó¾) and rare earth ion(Ln**) containing non-methyl canthridic acid radical |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500773A Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 06/02/2004 | CN1500524A Vehicle for topical delivery of anti-inflammatory compounds |
| 06/02/2004 | CN1500519A Medicinal liquor for treating rheumatism |
| 06/02/2004 | CN1500502A Medicine for adjusting qi and killing pain |
| 06/02/2004 | CN1500500A Freeze-dry snow lotus powder for venous injection and its preparation method |
| 06/02/2004 | CN1152048C Perfluoroalkyl ketone inhibitors of elastase and preparing method thereof |
| 06/02/2004 | CN1152030C Novel heterocyclic compounds |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1152006C Biphenyl derivatives |
| 06/02/2004 | CN1151820C Traditional Chinese medicine for treating rheumatic heart disease |
| 06/02/2004 | CN1151814C Traditonal Chinese medicine composition for treating rheumatic syndrome |
| 06/02/2004 | CN1151811C Pain-relieving compound notoginseng mixture formulation |
| 06/02/2004 | CN1151797C Tumor-blood-vessel growth inhibitor and medicinal composition |
| 06/02/2004 | CN1151787C Lactacystine analogs |
| 06/02/2004 | CN1151784C Quick absorption liquid composition |
| 06/01/2004 | US6743939 Phenylheteroalkylamine derivatives |
| 06/01/2004 | US6743816 Imidazole derivatives with anti-inflammatory activity |
| 06/01/2004 | US6743812 Pharmaceutical compositions and methods for use |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743800 Vitronectin receptor antagonists and inhibitors of cell adhesion; osteoporosis, angiogenesis inhibitors |
| 06/01/2004 | US6743798 Cardiovascular disorders; vasorelaxation, inhibition of platelet aggregation, decrease in blood pressure; stimulation of soluble guanylate cyclase and an intracellular cgmp increase |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743787 For therapy of metabolic disorders mediated by insulin resistance or hyperglycemia in a mammal |
| 06/01/2004 | US6743607 Production of complex carbohydrates |
| 06/01/2004 | US6743415 Delivery of anti-migraine compounds through an inhalation route |
| 06/01/2004 | US6743412 Administering to treat rheumatoid arthritis, cancer, restenosis |
| 06/01/2004 | US6742646 Systems, methods and apparatuses for manufacturing dosage forms |
| 05/27/2004 | WO2004044006A1 Conjugates of interleukin-10 and polymers |
| 05/27/2004 | WO2004043968A1 N-sulfonylaminothiazole |
| 05/27/2004 | WO2004043966A1 New tricyclic derivatives as ltd4 antagonists |
| 05/27/2004 | WO2004043959A1 Novel parp inhibitors |
| 05/27/2004 | WO2004043949A1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands |
| 05/27/2004 | WO2004043934A1 Celecoxib prodrug |
| 05/27/2004 | WO2004043925A2 3-substituted-6-aryl pyridined as ligands of c5a receptors |
| 05/27/2004 | WO2004043924A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/27/2004 | WO2004043468A1 Screening method |
| 05/27/2004 | WO2004017959A3 Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| 05/27/2004 | WO2004016583A8 Substituted glycine derivatives for use as medicaments |
| 05/27/2004 | WO2003104197A9 Polymorphic form xvi of fexofenadine hydrochloride |
| 05/27/2004 | WO2003088908A3 Heterocyclo inhibitors of potassium channel function |
| 05/27/2004 | WO2003081258A3 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003059276B1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 05/27/2004 | WO2003014089A8 Aminotetrahydroisoquinoline derivatives as analgesics |
| 05/27/2004 | WO2003006036A3 Herbal formulation |
| 05/27/2004 | WO2003006034A3 Herbal formulation |
| 05/27/2004 | WO2003002109A3 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 05/27/2004 | WO2002090375A8 Liver x receptor agonists |
| 05/27/2004 | WO2002060480A9 Methods for treating or preventing skin disorders using cd2-binding agents |
| 05/27/2004 | WO2002057284A8 New inhibitors against galectins |
| 05/27/2004 | US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease |
| 05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 05/27/2004 | US20040102522 Dosage form of sodium ibuprofen |
| 05/27/2004 | US20040102517 Novel1,2-diphenylethene derivatives for treatment of immune diseases |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102510 Cancer; the compounds interact with the amino acids in the catalytic region of PKs and bind in the general space normally occupied by the adenine ring of ATP |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102497 Novel inhibitors of IMPDH enzyme |
| 05/27/2004 | US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 05/27/2004 | US20040102492 Inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds. Ar1 is carbocycle optionally substituted with one R1, and wherein Ar1 |
| 05/27/2004 | US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease |
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102478 Alzheimer's and Parkinson's disease; antiinflamamtory agents; antiallergens; vision defects |
| 05/27/2004 | US20040102467 Antiinflammatory agents; central nervous system disorders; antiproliferative agents |
| 05/27/2004 | US20040102466 Analgesics; antipyretics; antiinflammatory agents |
| 05/27/2004 | US20040102464 Hypotensive agents; cardiovascular disorders; anticancer agents; headaches; antihistamines; antiinflamamtory agents |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102447 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102438 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 05/27/2004 | US20040102435 Alzheimer's disease; psychological disorders; anxiolytic agents; antidepressants; hormone replacement therapy |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102406 Phosphorothioate oligonucleotides directed to a subunit of an integrin vitronectin receptor to inhibit angiogenesis and/or metastasis |
| 05/27/2004 | US20040102384 Pyrrolidine derivatives and their use as chymase inhibitor |
| 05/27/2004 | US20040102381 Methods of altering the binding affinity of a peptide to its receptor |
| 05/27/2004 | US20040102376 Use of rgm and its modulators |
| 05/27/2004 | US20040102366 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids |
| 05/27/2004 | US20040101965 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/27/2004 | US20040101934 Beverage comprising peptide nerve growth factor conjugate for use in treatment of pain; analgesics; tranquilizers |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101875 Novel g protein-coupled receptor protein and dna thereof |
| 05/27/2004 | US20040101580 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 05/27/2004 | US20040101552 Pharmaceutical compositions |
| 05/27/2004 | US20040101508 Use of extracts of the plant litchi chinensis sonn. |
| 05/27/2004 | US20040101487 Combinations of formoterol and fluticasone propionate for asthma |
| 05/27/2004 | US20040098847 Funerary container made of paper material, and assembly device employed therein |
| 05/27/2004 | CA2505876A1 Novel parp inhibitors |